A large new study links common IBS drugs like loperamide and diphenoxylate to a higher risk of death. Experts say the risk is ...

A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...

LSL PHARMA GROUP INC. (TSXV: LSL) ("LSL Pharma" or the "Company"), a Canadian integrated pharmaceutical company, today ...

Several of the most common treatments for irritable bowel syndrome could raise the risk of death, a study from researchers at ...

Commonly used medications for irritable bowel syndrome (IBS), like antidepressants, are linked to a modest absolute increase in mortality risk. | Drug Discovery And Development ...

A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly prescribed to treat irritable bowel syndrome (IBS)—including ...

A long-term study links some IBS drugs, including antidepressants and anti-diarrhoeals, to a small increased death risk, ...

Researchers say some medications prescribed for irritable bowel syndrome (IBS) may increase a person’s risk of early death.

Research indicates that antidepressant use in IBS is linked to a 35% higher risk of all-cause mortality, highlighting safety issues with long-term treatment.

In A Nutshell Antidepressants, prescribed to more than half of IBS patients, were associated with a 35% higher relative risk ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. SEE ALSO: Live updates on ...